Hostname: page-component-cc8bf7c57-ksm4s Total loading time: 0 Render date: 2024-12-11T22:57:59.042Z Has data issue: false hasContentIssue false
  • English
  • Français

Memory in individuals with mild cognitive impairment in relation to APOE and CSF Aβ42

Published online by Cambridge University Press:  26 March 2010

Valgeir Thorvaldsson ,
Arto Nordlund ,
Ivar Reinvang ,
Kaj Blennow ,
Henrik Zetterberg ,
Anders Wallin  and
Boo Johansson
Valgeir Thorvaldsson*
Affiliation:
Department of Psychology, University of Gothenburg, Gothenburg, Sweden
Arto Nordlund
Affiliation:
Department of Psychiatry and Neurochemistry, University of Gothenburg, Sweden
Ivar Reinvang
Affiliation:
Department of Psychology, University of Oslo, Oslo, Norway
Kaj Blennow
Affiliation:
Department of Psychiatry and Neurochemistry, University of Gothenburg, Sweden
Henrik Zetterberg
Affiliation:
Department of Psychiatry and Neurochemistry, University of Gothenburg, Sweden
Anders Wallin
Affiliation:
Department of Psychiatry and Neurochemistry, University of Gothenburg, Sweden
Boo Johansson
Affiliation:
Department of Psychology, University of Gothenburg, Gothenburg, Sweden
*
Correspondence should be addressed to: Valgeir Thorvaldsson, Department of Psychology, University of Gothenburg, Box 500, SE-405 30 Gothenburg, Sweden. Phone: +46 (0)31 7861646; Fax: +46 (0)31 7864628. Email: [email protected].
Get access Rights & Permissions [Opens in a new window]

Abstract

Background: The ε4 allele of the apolipoprotein E (APOE) gene and low levels of cerebrospinal fluid (CSF) amyloid β-proteins 42 (Aβ) have previously been associated with increased risk of cognitive decline in old age. In this study we examine the interaction of these markers with episodic memory in a sample identified as having mild cognitive impairment (MCI).

Methods: The sample (N = 149) was drawn from the Gothenburg MCI study and measured according to three free recall tests on three occasions spanning over four years. Second-order Latent Curve Models (LCM) were fitted to the data.

Results: Analyses accounting for age, gender, education, APOE, Aβ42, and interaction between APOE and Aβ42 revealed that the ε4 allele was significantly associated with level of memory performance in the presence of low Aβ42 values (≤452 ng/L). Associations between memory performance and Aβ42 were significant among the ε4 carriers but not among the non-carriers. The Aβ42 marker was, however, significantly associated with changes in memory over the study time period in the total sample.

Conclusion: The findings support the hypothesis of an interactive effect of APOE and Aβ42 for memory decline in MCI patients.

Keywords

memoryapolipoprotein Eamyloid β42longitudinal study
Type
Research Article
Information
International Psychogeriatrics , Volume 22 , Issue 4 , June 2010 , pp. 598 - 606
Copyright
Copyright © International Psychogeriatric Association 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Albert, M. S., and Blacker, D. (2006). Mild cognitive impairment and dementia. Annual Review of Clinical Psychology, 2, 379–388.CrossRefGoogle ScholarPubMed
Andreasen, N. et al. (1999). Cerebrospinal fluid β-amyloid(1–42) in Alzheimer disease. Archives of Neurology, 56, 673–680.CrossRefGoogle ScholarPubMed
Bennett, D. A., Schneider, J. A., Wilson, R. S., Bienias, J. L., Karvis, E. B. and Arnold, S. E. (2005). Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people. Journal of Neurology, Neurosurgery and Psychiatry, 76, 1194–1199.CrossRefGoogle ScholarPubMed
Bentler, P. M. (1990). Comparative fit indexes in structural models. Psychological Bulletin, 107, 238–246.CrossRefGoogle ScholarPubMed
Blennow, K. et al. (2000). No association between the alpha2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein expression. Journal of Neural Transmission, 107, 1065–1079.CrossRefGoogle Scholar
Blennow, K., de Leon, M. and Zetterberg, H. (2006). Alzheimer's disease. Lancet, 368, 387–403.CrossRefGoogle ScholarPubMed
Bondi, M. W., Salmon, D. P., Galasko, D., Thomas, R. G. and Thal, L. J. (1999). Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Psychology and Aging, 14, 295–303.CrossRefGoogle ScholarPubMed
Deary, I. J. et al. (2002). Cognitive change and the APOE epsilon 4 allele. Nature, 418, 932.CrossRefGoogle ScholarPubMed
Erkinjuntti, T. et al. (2000). Research criteria for subcortical vascular dementia in clinical trials. Journal of Neural Transmission. Supplementum, 59, 23–30.Google ScholarPubMed
Farlow, M. R., He, Y., Tekin, S., Xu, J., Lane, R. and Charles, H. C. (2004). Impact of APOE in mild cognitive impairment. Neurology, 63, 1898–1901.CrossRefGoogle ScholarPubMed
Farrer, L. A. et al. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. APOE and Alzheimer Disease Meta analysis Consortium. JAMA, 278, 1349–1356.CrossRefGoogle ScholarPubMed
Ferrer, E., Balluerka, N., and Widaman, K. F. (2008). Factorial invariance and the specification of second-order latent growth models. Methodology, 4, 22–36.CrossRefGoogle ScholarPubMed
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.CrossRefGoogle ScholarPubMed
Geffen, G. M., Butterworth, P. and Geffen, L. B. (1994). Test-retest reliability of a new form of the auditory verbal learning test (AVLT). Archives of Clinical Neuropsychology, 9, 303–316.CrossRefGoogle ScholarPubMed
Hansson, O.Zetterberg, H., Buchhave, P., Londos, E., Blennow, K. and Minthon, L. (2006). Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurology, 5, 228–234.CrossRefGoogle ScholarPubMed
Hardy, J. and Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 297, 353–356.CrossRefGoogle ScholarPubMed
Hofer, S. M. et al. (2002). Change in cognitive functioning associated with apoE genotype in a community sample of older adults. Psychology and Aging, 17, 194–208.CrossRefGoogle Scholar
Jorm, A. F., Mather, K. A., Butterworth, P., Anstey, K. J., Christensen, H. and Easteal, S. (2007). APOE genotype and cognitive functioning in a large age-stratified population sample. Neuropsychology, 21, 1–8.CrossRefGoogle Scholar
Luciano, M. et al. (2009). Apolipoprotein E is not related to memory abilities at 70 years of age. Behavior Genetics, 39, 6–14.CrossRefGoogle ScholarPubMed
Mahley, R. W., Weisgraber, K. H. and Huang, Y. (2006). Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America, 103, 5644–5651.CrossRefGoogle ScholarPubMed
McArdle, J. J. (1988). Dynamic but structural equation modeling of repeated measures data. In Nesselroade, J. R. and Cattell, R. B. (eds.) Handbook of Multivariate Experimental Psychology (2nd edn), (pp. 561–614). New York: Plenum Press.CrossRefGoogle Scholar
McArdle, J. J. and Nesselroade, J. R. (2003). Growth curve analysis in contemporary psychological research. In Schinka, J. and Velicer, W. (Eds.)Comprehensive Handbook of Psychology: Vol 2. Research Methods in Psychology (pp. 447–480). New York: Pergamon Press.CrossRefGoogle Scholar
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939–944.CrossRefGoogle ScholarPubMed
Meredith, W. and Horn, J. (2001). The role of factorial invariance in modeling growth and change. In Collins, L. M. and Sayer, A. G. (eds.), New Methods for the Analysis of Change (pp. 203–240). Washington, DC: American Psychological Association.CrossRefGoogle Scholar
Meyers, J. M. and Meyers, K. R. (1995). Rey Complex Figure Test and Recognition Trial. Odessa: Psychological Assessment Resources, Inc.Google Scholar
Morris, J. C. (1997). Clinical dementia rating: a reliable and valid diagnostic staging measure for dementia of the Alzheimer type. International Psychogeriatrics, 9, 173–176.CrossRefGoogle ScholarPubMed
Nilsson, L-G. et al. (2006). The influence of APOE status on episodic and semantic memory: Data from a population-based study. Neuropsychology, 20, 645–657.CrossRefGoogle ScholarPubMed
Nordlund, A., Rolstad, S., Hellström, P., Sjögren, M., Hansen, S. and Wallin, A. (2005). The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition. Journal of Neurology, Neurosurgery and Psychiatry, 76, 1485–1490.CrossRefGoogle ScholarPubMed
Ramakers, I. H. G. B. et al. (2008). The association between APOE genotype and memory dysfunction in subjects with mild cognitive impairment is related to age and Alzheimer pathology. Dementia and Geriatric Cognitive Disorders, 26, 101–108.CrossRefGoogle ScholarPubMed
Rosen, V. M., Bergeson, J. L., Putnam, K., Harwell, A. and Sunderland, T. (2002). Working memory and apolipoprotein E: What's the connection? Neuropsychologia, 40, 2226–2233.CrossRefGoogle ScholarPubMed
Royall, D. R., Mahurin, R. K. and Gray, K. F. (1992). Bedside assessment of executive cognitive impairment: the executive interview. Journal of the American Geriatrics Society, 40, 1221–1226.CrossRefGoogle ScholarPubMed
Stenset, V. et al. (2006). Association between white matter lesions, cerebrovascular risk factors, and low CSF Aβ42. Neurology, 67, 830–833.CrossRefGoogle ScholarPubMed
Steiger, J. H. (1990). Structural model evaluation and modification: an interval estimation approach. Multivariate Behavioral Research, 25, 173–180.CrossRefGoogle ScholarPubMed
Strozyk, D., Blennow, K., White, L. R. and Launer, L. J. (2003). CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology, 25, 652–656.CrossRefGoogle Scholar
Wallin, A. et al. (1996). Stepwise comparative status analysis (STEP): a tool for identification of regional brain syndromes in dementia. Journal of Geriatric Psychiatry and Neurology, 9, 185–199.CrossRefGoogle ScholarPubMed
Wechsler, D. (1987). Wechsler Memory Scale – Revised Manual. San Antonio, TX: Psychological Corporation.Google Scholar
Wehling, E., Lundervold, A. J., Standnes, B., Gjerstad, L. and Reinvang, I. (2007). APOE status and its association to learning and memory performance in middle aged and older Norwegians seeking assessment for memory deficits. Behavioral and Brain Functions, 3, 57.CrossRefGoogle ScholarPubMed
Willett, J. B. and Bub, K. L. (2005). Latent growth curve analysis. In Rindskopf, D. (ed.), Encyclopedia of Statistics in Behavioral Science (2nd edn). Oxford: Wiley.Google Scholar
Winblad, B. et al. (2004). Mild cognitive impairment: beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine, 256, 240–246.CrossRefGoogle Scholar